Partner Article

Algeos secures £2m Middle East contract

Medical products specialist Algeos has won a contract in the Middle East worth more than £2m.

The Liverpool-based company has secured the tender with the Gulf Cooperation Council to supply a range of products to countries including Kuwait, Saudi Arabia, Bahrain, Qatar, Oman and the United Arab Emirates.

The contract will see Algeos, which is headquartered in Speke, distributing products including orthotic and prosthetic materials and components, diabetic foot products and orthopaedic bracing.

The latest success follows on from a previous tender won by the company with the GCC. Algeos received advice and support from UKTI as part of Algeos’ wider global expansion plans.

Hugh Sheridan, CEO of ALG, which owns Algeos, said: “Winning the GCC tender reinforces our position in the Middle East and demonstrates our capabilities in the face of global competition from corporate players in the United States and Germany.

“We are the only western company to have a dedicated office in the Middle East, a sign of our commitment to the region. We are also unique in being able to offer products covering podiatry, physiotherapy and O&P.

“Tender successes such as this are also reward for the significant investment we continue to make in training and education in the Middle East and elsewhere in the world.

“In order to secure this work, we had to go through an extremely rigorous and challenging process, but in being successful we have ensured that our company’s global growth plans remain very much on track.”

ALG International Holdings achieved turnover of £12m in 2014, up from £10.7m in the previous year.

This was posted in Bdaily's Members' News section by Ellen Forster .